GNH USA

Europe — EMA

Orebriton (Ticagrelor)

Ticagrelor, the active ingredient in Orebriton, is an antiplatelet medication presented as a tablet for oral use. It reduces the risk of thrombotic cardiovascular events in patients with acute coronary syndrome and…

Request sourcing

1
Pack/s

What is Ticagrelor?

Ticagrelor, the active ingredient in Orebriton, is an antiplatelet medication presented as a tablet for oral use. It reduces the risk of thrombotic cardiovascular events in patients with acute coronary syndrome and those undergoing .

GNH USA supplies Orebriton as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Ticagrelor used for?

Orebriton acts   ...  .... … .... .... ... .... ... .... ... .... ... ... """  "  """  ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Ticagrelor
Route
Oral Use
Manufacturer
Zentiva, K.S.
Origin
EU

Related products